Elevated brain lactate in schizophrenia: a 7 T magnetic resonance spectroscopy study

Various lines of evidence suggest that brain bioenergetics and mitochondrial function may be altered in schizophrenia. On the basis of prior phosphorus-31 (31P)-magnetic resonance spectroscopy (MRS), post-mortem and preclinical studies, this study was designed to test the hypothesis that abnormal glycolysis leads to elevated lactate concentrations in subjects with schizophrenia. The high sensitivity of 7 Tesla proton (1H)-MRS was used to measure brain lactate levels in vivo. Twenty-nine controls and 27 participants with schizophrenia completed the study. MRS scanning was conducted on a Philips ‘Achieva’ 7T scanner, and spectra were acquired from a voxel in the anterior cingulate cortex. Patients were assessed for psychiatric symptom severity, and all participants completed the MATRICS Consensus Cognitive Battery (MCCB) and University of California, San Diego Performance-Based Skills Assessment (UPSA). The relationship between lactate, psychiatric symptom severity, MCCB and UPSA was examined. Lactate was significantly higher in patients compared with controls (P=0.013). Higher lactate was associated with lower MCCB (r=−0.36, P=0.01) and UPSA total scores (r=−0.43, P=0.001). We believe this is the first study to report elevated in vivo cerebral lactate levels in schizophrenia. Elevated lactate levels in schizophrenia may reflect increased anaerobic glycolysis possibly because of mitochondrial dysfunction. This study also suggests that altered cerebral bioenergetics contribute to cognitive and functional impairments in schizophrenia.

[1]  T. Crawford,et al.  Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. , 2003, AJNR. American journal of neuroradiology.

[2]  P. Moreira Alzheimer's disease and diabetes: an integrative view of the role of mitochondria, oxidative stress, and insulin. , 2012, Journal of Alzheimer's disease : JAD.

[3]  R. Gruetter,et al.  N-Acetylcysteine Normalizes Neurochemical Changes in the Glutathione-Deficient Schizophrenia Mouse Model During Development , 2012, Biological Psychiatry.

[4]  R. Paz,et al.  Long-Term Treatment of Rats with Haloperidol: Lack of an Effect on Brain N-Acetyl Aspartate Levels , 2006, Neuropsychopharmacology.

[5]  L. Szweda,et al.  α-Ketoglutarate dehydrogenase: A mitochondrial redox sensor , 2011, Free radical research.

[6]  M. Krams,et al.  Impaired mitochondrial function in psychiatric disorders , 2012, Nature Reviews Neuroscience.

[7]  Mark Slifstein,et al.  Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. , 2012, Archives of general psychiatry.

[8]  R. Gruetter,et al.  Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis. , 2016, Schizophrenia bulletin.

[9]  P. Renshaw,et al.  Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research , 2005, Molecular Psychiatry.

[10]  A. Lahti,et al.  Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia , 2015, Schizophrenia Research.

[11]  A. Kulak N-ACETYLCYSTEINE NORMALIZES NEUROCHEMICAL CHANGES IN THE GLUTATHIONE-DEFICIENT SCHIZOPHRENIA MOUSE MODEL DURING DEVELOPMENT , 2012, Schizophrenia Research.

[12]  J. Finsterer,et al.  Cognitive dysfunction in mitochondrial disorders , 2012, Acta neurologica Scandinavica.

[13]  J. Gold,et al.  Next-generation negative symptom assessment for clinical trials: Validation of the Brief Negative Symptom Scale , 2012, Schizophrenia Research.

[14]  G. Sutherland,et al.  Lactate Storm Marks Cerebral Metabolism following Brain Trauma* , 2014, The Journal of Biological Chemistry.

[15]  J. Knoefel,et al.  The neuropathology and cerebrovascular mechanisms of dementia , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[16]  R. Gruetter,et al.  In vivo 1H NMR spectroscopy of rat brain at 1 ms echo time , 1999, Magnetic resonance in medicine.

[17]  Roger J. Ordidge,et al.  THE CORRECTION OF TRANSIENT B0 FIELD SHIFTS FOLLOWING THE APPLICATION OF PULSED GRADIENTS BY PHASE CORRECTION IN THE TIME DOMAIN , 1986 .

[18]  B. Cohen,et al.  In vivo evidence for cerebral bioenergetic abnormalities in schizophrenia measured using 31P magnetization transfer spectroscopy. , 2014, JAMA psychiatry.

[19]  S. A. Wijtenburg,et al.  Frontal Glutamate and γ-Aminobutyric Acid Levels and Their Associations With Mismatch Negativity and Digit Sequencing Task Performance in Schizophrenia. , 2016, JAMA psychiatry.

[20]  Michael F. Green,et al.  Evaluation of functionally meaningful measures for clinical trials of cognition enhancement in schizophrenia. , 2011, The American journal of psychiatry.

[21]  R. Caivano,et al.  3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature , 2013, The International journal of neuroscience.

[22]  Ravi S. Menon,et al.  Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.

[23]  Roland Kreis,et al.  The trouble with quality filtering based on relative Cramér‐Rao lower bounds , 2016, Magnetic resonance in medicine.

[24]  A. Graff-Guerrero,et al.  Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study. , 2013, JAMA psychiatry.

[25]  D. Ben-shachar,et al.  Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia , 2016, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[26]  A. Lahti,et al.  Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia. , 2013, JAMA psychiatry.

[27]  S. Woods,et al.  Chlorpromazine equivalent doses for the newer atypical antipsychotics. , 2003, The Journal of clinical psychiatry.

[28]  Peter B Barker,et al.  Comparison of single voxel brain MRS AT 3T and 7T using 32-channel head coils. , 2015, Magnetic resonance imaging.

[29]  S. Mathew,et al.  Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder , 2010, NMR in biomedicine.

[30]  R. Conley,et al.  Elevated Cerebrospinal Fluid Lactate Concentrations in Patients with Bipolar Disorder and Schizophrenia: Implications for the Mitochondrial Dysfunction Hypothesis , 2009, Biological Psychiatry.

[31]  Michael Schär,et al.  Optimized detection of lactate at high fields using inner volume saturation , 2006, Magnetic resonance in medicine.

[32]  A. Graff-Guerrero,et al.  Higher Levels of Glutamate in the Associative-Striatum of Subjects with Prodromal Symptoms of Schizophrenia and Patients with First-Episode Psychosis , 2011, Neuropsychopharmacology.

[33]  Rolf Gruetter,et al.  MR spectroscopy of the human brain with enhanced signal intensity at ultrashort echo times on a clinical platform at 3T and 7T , 2009, Magnetic resonance in medicine.

[34]  Linda Chang,et al.  Brain Metabolite Abnormalities in the White Matter of Elderly Schizophrenic Subjects: Implication for Glial Dysfunction , 2007, Biological Psychiatry.

[35]  R. Murray,et al.  Antipsychotic Treatment Resistance in Schizophrenia Associated with Elevated Glutamate Levels but Normal Dopamine Function , 2014, Biological Psychiatry.

[36]  R. Liberman,et al.  Consistency of Brief Psychiatric Rating Scale Factor Structure across a Broad Spectrum of Schizophrenia Patients , 2007, Psychopathology.

[37]  F. Turkheimer,et al.  Treatment-Resistant Schizophrenia Patients Show Elevated Anterior Cingulate Cortex Glutamate Compared to Treatment-Responsive. , 2016, Schizophrenia bulletin.

[38]  Mahaveer Degaonkar,et al.  Metabolites in ventricular cerebrospinal fluid detected by proton magnetic resonance spectroscopic imaging , 2004, Journal of magnetic resonance imaging : JMRI.

[39]  J. Dennis,et al.  Mitochondrial Dysfunction in Alzheimer’s Disease and the Rationale for Bioenergetics Based Therapies , 2016, Aging and disease.

[40]  S. Provencher Automatic quantitation of localized in vivo 1H spectra with LCModel , 2001, NMR in biomedicine.

[41]  K. Uğurbil,et al.  In vivo 1H NMR spectroscopy of the human brain at high magnetic fields: Metabolite quantification at 4T vs. 7T , 2009, Magnetic resonance in medicine.

[42]  Rolf Gruetter,et al.  Are glutamate and lactate increases ubiquitous to physiological activation? A 1H functional MR spectroscopy study during motor activation in human brain at 7Tesla , 2014, NeuroImage.

[43]  D. Klomp,et al.  Detection of lactate in the striatum without contamination of macromolecules by J‐difference editing MRS at 7 T , 2015, NMR in biomedicine.

[44]  J. Kleinman,et al.  Increased lactate levels and reduced pH in postmortem brains of schizophrenics: Medication confounds , 2008, Journal of Neuroscience Methods.

[45]  Michael F. Green,et al.  Approaching a consensus cognitive battery for clinical trials in schizophrenia: The NIMH-MATRICS conference to select cognitive domains and test criteria , 2004, Biological Psychiatry.

[46]  N. Logothetis,et al.  Dynamics of lactate concentration and blood oxygen level‐dependent effect in the human visual cortex during repeated identical stimuli , 2007, Journal of neuroscience research.

[47]  Jun-Feng Wang,et al.  Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. , 2009, Bipolar disorders.

[48]  J. Lauriello,et al.  1H-MRS at 4 Tesla in minimally treated early schizophrenia , 2010, Molecular Psychiatry.

[49]  M. Beal Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[50]  α-Ketoglutarate Dehydrogenase: A Mitochondrial Redox Sensor , 2010 .

[51]  Kevin Murphy,et al.  Temporal dynamics of lactate concentration in the human brain during acute inspiratory hypoxia , 2013, Journal of magnetic resonance imaging : JMRI.

[52]  Clifford Qualls,et al.  Increased glutamine in patients undergoing long-term treatment for schizophrenia: a proton magnetic resonance spectroscopy study at 3 T. , 2014, JAMA psychiatry.

[53]  Ravi S. Menon,et al.  Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. , 2003, The American journal of psychiatry.

[54]  R. Yolken,et al.  Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress , 2004, Molecular Psychiatry.